Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Enzymatic catalysis in nonaqueous solvents.
The rate enhancements afforded by chymotrypsin and subtilisin in the transesterification reaction in octane are of the order of 100 billion-fold; covalent modification of the active center of the enzymes by a site-specific reagent renders them catalytically inactive in organic solvents. Expand
Key green chemistry research areas—a perspective from pharmaceutical manufacturers
In 2005, the ACS Green Chemistry Institute (GCI) and the global pharmaceutical corporations developed the ACS GCI Pharmaceutical Roundtable to encourage the integration of green chemistry and green… Expand
The effect of water on enzyme action in organic media.
It is concluded that the water required by enzymes in nonaqueous solvents provides them with sufficient conformational flexibility needed for catalysis. Expand
Enzymatic catalysis in organic media at 100 degrees C.
Porcine pancreatic lipase catalyzes the transesterification reaction between tributyrin and various primary and secondary alcohols in a 99 percent organic medium and exhibits a high catalytic activity at that temperature. Expand
Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli
- R. B. Vail, M. J. Homann, Imad Hanna, A. Zaks
- Chemistry, Medicine
- Journal of Industrial Microbiology and…
- 1 March 2005
Three human cytochrome P450s were each co-expressed with NADPH-P450 reductase in Escherichia coli and used in the preparative synthesis of drug metabolites to establish an efficient bioconversion system for the generation of metabolites. Expand
Enzyme-catalyzed processes in organic solvents.
Three different lipases (porcine pancreatic, yeast, and mold) can vigorously act as catalysts in a number of nearly anhydrous organic solvents. Various transesterification reactions catalyzed by… Expand
Efficient, chemoenzymatic process for manufacture of the Boceprevir bicyclic [3.1.0]proline intermediate based on amine oxidase-catalyzed desymmetrization.
- T. Li, Jack Liang, +12 authors Xiyun Zhang
- Chemistry, Medicine
- Journal of the American Chemical Society
- 28 March 2012
The key structural feature in Boceprevir, Merck's new drug treatment for hepatitis C, is the bicyclic [3.1.0]proline moiety "P2", which is an enzymatic oxidative desymmetrization of the prochiral amine substrate. Expand
Chloroperoxidase‐Catalyzed Asymmetric Oxidations: Substrate Specificity and Mechanistic Study.
Rapid identification of enantioselective ketone reductions using targeted microbial libraries
A collection of about 300 microbes was surveyed for the ability to generate chiral secondary alcohols by enantioselective reduction of a series of alkyl aryl ketones. Microbial cultures demonstrating… Expand
Enzymatic Desymmetrization of Prochiral 2-Substituted-1,3-propanediols: A Practical Chemoenzymatic Synthesis of a Key Precursor of SCH51048, a Broad-Spectrum Orally Active Antifungal Agent
Two examples of a practical enzymatic desymmetrization of a 2-substituted-1,3-propanediol and their application to the synthesis of SCH51048, a broad-spectrum orally active antifungal, are described.… Expand